Brown adipose tissue (BAT) possesses atypical f3-adrenoceptors (fi3) which stimulate energy expenditure by increasing lipogenesis and thermogenesis. Holloway et al. (1991) reported that ICI D7114 selectively stimulates these atypical k3-receptors, increasing BAT oxygen consumption and thermogenesis.We have previously reported that CBA/Ca obese diabetic mice exhibit reduced lipogenesis compared to normal littermates (Al-Qatari et al. 1991) .In vivo lipogenesis rates were estimated by measuring the incorporation of 3H into fatty acids extracted from adipose tissue following I.P. injection of 3H20 (Mercer & Trayhurn, 1983). D7114 was administered either chronically in the food (dose equivalent to 3 mg (kg body weight)-l day-' for 3 weeks) or acutely (5 mg kg-' I.P.) 1 hour prior to 3H20 injection. Insulin (1 IU kg-' I.P.) was injected 15 minutes before 3H20. Mitochrondrial activity was monitored by measuring the specific activity of cytochrome oxidase.Acute D7114 significantly increased basal BAT lipogenesis rates from 63.7 ± 0.6 to 109.9 ± 16.9 jug atoms H incorporated h-' (g fat-free tissue weight)-l (means ± S.E.M., n = 10-13; P < 0.03, t test). Chronic treatment with D7114 also increased BAT lipogenesis by 61 % above controls. In contrast, insulinstimulated BAT lipogenesis was lower following acute D7114: 60.0 ± 7.0 compared with 119.9 ± 20.2 (n = 9-14) in controls. Basal and insulin-stimulated lipogenesis in white adipose tissue (epididymal fat pads) was unaltered by either acute or chronic D7114. Chronic D7114 treatment significantly increased cytochrome c oxidase activity (P < 0.01, t test): 22.5 ± 2.3 compared with 13.1 ± 1.3,umol cyto c min-' in controls. Acute D7114 had no effect on cytochrome c oxidase activity.These results demonstrate that D7114 is effective in increasing basal rates of BAT lipogenesis in obese diabetic mice and that chronic dosing increases mitochondrial activity, thus increasing energy expenditure.We are grateful to ICI Pharmaceuticals for supplies of D7114.